Health

Results: 433-444 of 9489

Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo

Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors

EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss

Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase)

PR Newswire associated0

CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union

PR Newswire associated0

Novo Nordisk to showcase new data across its hemophilia portfolio at the ISTH Congress 2026, featuring investigational denecimig

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis

Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy

Tilray Medical Expands Medical Cannabis Access for Veterans Through Lyphe Clinic at Aldershot’s Armed Forces Weekend

DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP

Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 2026